Neurofibromatosis types 1 and 2

The Neurologist
Kaleb Yohay

Abstract

Neurofibromatosis types 1 and 2 (NF1 and NF2) are autosomal dominant neurocutaneous disorders with some similarities and many differences. They are frequently discussed together and often confused for one another by clinicians. Both disorders have widely variable presentations and degrees of severity. A thorough understanding of these complex disorders is essential for proper medical management, anticipatory care, and patient education. In this article, the clinical features, genetics, pathogenesis, and management of neurofibromatosis types 1 and 2 are reviewed and compared. NF1 and NF2 are complex genetic disorders with numerous manifestations and wide phenotypic variability. The complex nature of these disorders requires coordinated multidisciplinary care.

References

May 1, 1990·Journal of Medical Genetics·M Littler, N E Morton
May 1, 1989·The Journal of Pediatrics·R ListernickN B Esterly
Dec 31, 1981·The New England Journal of Medicine·V M Riccardi
Nov 1, 1995·American Journal of Ophthalmology·N K RaggeV M Riccardi
Dec 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·E LegiusJ P Fryns
May 1, 1995·Developmental Medicine and Child Neurology·K NorthP Hutchins
Nov 1, 1994·Nature Genetics·R A HeimM C Luce
Nov 24, 1994·The New England Journal of Medicine·C LázaroX Estivill
Apr 1, 1994·The Journal of Pediatrics·K J HofmanM B Denckla
Jun 1, 1996·Journal of the Neurological Sciences·R E FernerJ Weinman
Jul 2, 1997·JAMA : the Journal of the American Medical Association·D H GutmannD Viskochil
Jan 8, 1999·Pediatric Neurology·K Kulkantrakorn, T J Geller
Jun 9, 1999·American Journal of Medical Genetics·D A StevensonJ C Carey
Dec 20, 1999·Journal of Agricultural and Food Chemistry·M Friedman
Aug 24, 2000·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·E FossaliL N Rossi
Jan 11, 2000·Journal of Medical Genetics·J SzudekJ M Friedman
Apr 3, 2001·American Journal of Human Genetics·S A RasmussenJ M Friedman
Jun 27, 2001·Neurology·J M GijtenbeekB G van Engelen
Apr 19, 2002·Brain : a Journal of Neurology·A D SperfeldC O Hanemann
May 16, 2002·Journal of Medical Genetics·D G R EvansA Moran
Aug 16, 2002·Genetics in Medicine : Official Journal of the American College of Medical Genetics·J M FriedmanBruce R Korf
Jun 11, 2004·American Journal of Human Genetics·Michael E BaserD Gareth R Evans
Apr 20, 2005·Journal of Vascular Surgery·Myo Han, Enrique Criado

❮ Previous
Next ❯

Citations

Oct 12, 2007·Archives of Orthopaedic and Trauma Surgery·Gautam M ShettyJae Hyuk Yang
Aug 2, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Amit KochharRichard J H Smith
Nov 4, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Howard P LevyDiane C Seibert
Aug 1, 2012·The Cancer Journal·Michele Gabree, Meredith Seidel
Mar 29, 2011·Orphanet Journal of Rare Diseases·Maria MasoccoDomenica Taruscio
Apr 22, 2009·European Journal of Medical Research·Jan VesperG Lammering
Apr 12, 2006·American Journal of Clinical Dermatology·C Elise KleynHazel K Bell
Mar 11, 2010·Clinical Oral Investigations·George João Ferreira do NascimentoLélia Batista de Souza
Mar 1, 2008·Expert Opinion on Medical Diagnostics·Oana Vele, Iris Schrijver
Apr 23, 2008·Pathology·Nicola WayteSunil R Lakhani
Dec 12, 2007·The Journal of Hand Surgery·Asif M IlyasJesse B Jupiter
Feb 24, 2007·Pathology, Research and Practice·Mathias LöttrichBernd Freigang
Dec 6, 2008·Surgical Oncology Clinics of North America·Colin M ParsonsVijay P Khatri
Mar 2, 2010·Neurosurgery·Allan D LeviH Thomas Temple
Aug 21, 2009·Multiple Sclerosis : Clinical and Laboratory Research·M EtemadifarA H Maghzi
Dec 26, 2009·International Journal of Surgical Pathology·Peter PytelAnthony G Montag
Jul 25, 2007·Journal of Forensic Sciences·Roger W Byard
Apr 22, 2009·European Journal of Medical Research·P A GerberE Bölke
Apr 1, 2020·JBJS Reviews·Jana DenglerAmy M Moore

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.